Sort
82,697 grants matching “vaccine development”
Consolidated Basic Cancer Research Program
$2,719,954Dario C. Altieri · Wistar Institute · P30 · FY2020 · CA
Allogeneic and Autologous Immunotherapy for cancer and nonmalignant hematological disorders
$2,719,866Richard Childs · National Heart, Lung, And Blood Institute · ZIA · FY2016 · HL
Advanced Development and Clinical Evaluation of an Entamoeba histolytica Vaccine
$2,719,618Access To Advanced Health Institute · N01 · FY2018 · AI
Task 14/C31: Efficacy Testing of Drugs Against Inhalational Anthrax in Rabbits
$2,719,474Judy Britt · Southern Research Institute · N01 · FY2009 · AI
Development of a Vaccine for HIVAIDS: Humoral Immunity
$2,718,739Marjorie Robert-Guroff · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Consortium for Viral Systems Biology (CViSB)
$2,718,625Kristian Graugaard Andersen · Scripps Research Institute, The · U19 · FY2021 · AI
Development of a COVID-19 Vaccine
$2,717,614Steven Reed · Hdt Bio Corporation · N01 · FY2022 · AI
The Development and Evaluation of Pan-Coronavirus Vaccines
$2,716,452Michael S. Diamond · Washington University · P01 · FY2025 · AI
Vanderbilt HIV Clinical Trials Unit
$2,716,438David W Haas · Vanderbilt University · UM1 · FY2014 · AI
Small molecule stimulators for use as adjuvants for antiviral vaccines
$2,715,449Michael Gale · University Of Washington · N01 · FY2013 · AI
SPORE in Prostate Cancer
$2,715,008Peter T Scardino · Sloan-Kettering Inst Can Research · P50 · FY2008 · CA
Consolidated Basic Cancer Research Program
$2,714,982Dario C. Altieri · Wistar Institute · P30 · FY2023 · CA
Consolidated Basic Cancer Research Program
$2,714,982Dario C. Altieri · Wistar Institute · P30 · FY2022 · CA
Consolidated Basic Cancer Research Program
$2,714,982Dario C. Altieri · Wistar Institute · P30 · FY2021 · CA
Harnessing CD4+ T cell responses for long-term protective immunity against HIV
$2,714,796Rafi Ahmed · Scripps Research Institute, The · UM1 · FY2018 · AI
Functional and dysfunctional human CD4 T cell and B cell responses to bacteria and viruses
$2,714,133Shane P Crotty · La Jolla Institute For Immunology · U19 · FY2022 · AI
Development of vaccines to bacterial diseases found especially in children
$2,713,785John Robbins · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · Z01 · FY2008 · HD
Functional and dysfunctional human CD4 T cell and B cell responses to bacteria and viruses
$2,713,421Shane P Crotty · La Jolla Institute For Immunology · U19 · FY2023 · AI
SPORE in Skin Cancer
$2,712,962Brigham And Women'S Hospital · P50 · FY2001 · CA
Developing Immunogens to Elicit Broadly Neutralizing anti-HIV-1 Antibodies
$2,711,483Pamela J Bjorkman · California Institute Of Technology · P01 · FY2020 · AI
Regulation of innate immunity by self-adjuvated MRNA vaccines
$2,710,680Chinnaswamy Jagannath · Methodist Hospital Research Institute · R01 · FY2025 · AI
HIV/AIDS Clinical Trials Units University of Cape Town CTU 2020 to 2027
$2,709,730Linda-Gail Bekker · University Of Cape Town · UM1 · FY2024 · AI
Mucusal and Systemic Immunity, Vaccines and Microbiota Interplay in Humans
$2,709,545Marcelo B. Sztein · University Of Maryland Baltimore · U19 · FY2014 · AI
Cincinnati Children's Hospital Medical Center Vaccine and Treatment Evaluation Units (UM1 Clinical Trial Required)
$2,708,294Robert Wilson Frenck · Cincinnati Childrens Hosp Med Ctr · UM1 · FY2022 · AI
Research Project 1: Discovery and dissection of virus-host interactions and pathogenetic mechanisms
$2,708,082Kartik Chandran · Albert Einstein College Of Medicine · U19 · FY2024 · AI